相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。The Antiresorptive Effect of GIP, But Not GLP-2, Is Preserved in Patients With Hypoparathyroidism-A Randomized Crossover Study
Kirsa Skov-Jeppesen et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2021)
Enhanced agonist residence time, internalization rate and signalling of the GIP receptor variant [E354Q] facilitate receptor desensitization and long-term impairment of the GIP system
Maria Buur Nordskov Gabe et al.
BASIC & CLINICAL PHARMACOLOGY & TOXICOLOGY (2020)
GIP analogues augment bone strength by modulating bone composition in diet-induced obesity in mice
Sagar S. Vyavahare et al.
PEPTIDES (2020)
GIP's effect on bone metabolism is reduced by the selective GIP receptor antagonist GIP(3-30)NH2
Laerke S. Gasbjerg et al.
BONE (2020)
Consumption of nutrients and insulin resistance suppress markers of bone turnover in subjects with abdominal obesity
Rasmus Fuglsang-Nielsen et al.
BONE (2020)
The role of endogenous GIP and GLP-1 in postprandial bone homeostasis
Mads M. Helsted et al.
BONE (2020)
Gut Hormones and Their Effect on Bone Metabolism. Potential Drug Therapies in Future Osteoporosis Treatment
Sine Paasch Schiellerup et al.
FRONTIERS IN ENDOCRINOLOGY (2019)
GLP-2 and GIP exert separate effects on bone turnover: A randomized, placebo-controlled, crossover study in healthy young men
Kirsa Skov-Jeppesen et al.
BONE (2019)
Glucose-Dependent Insulinotropic Polypeptide (GIP) Inhibits Bone Resorption Independently of Insulin and Glycemia
Mikkel B. Christensen et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2018)
Use of bone turnover markers in postmenopausal osteoporosis
Richard Eastell et al.
LANCET DIABETES & ENDOCRINOLOGY (2017)
Effects of meal and incretins in the regulation of splanchnic blood flow
Jukka Koffert et al.
ENDOCRINE CONNECTIONS (2017)
The Gluco- and Liporegulatory and Vasodilatory Effects of Glucose-Dependent Insulinotropic Polypeptide (GIP) Are Abolished by an Antagonist of the Human GIP Receptor
Meena Asmar et al.
DIABETES (2017)
Species-specific action of (Pro3)GIP - a full agonist at human GIP receptors, but a partial agonist and competitive antagonist at rat and mouse GIP receptors
A. H. Sparre-Ulrich et al.
BRITISH JOURNAL OF PHARMACOLOGY (2016)
Response of bone turnover markers to three oral bisphosphonate therapies in postmenopausal osteoporosis: the TRIO study
K. E. Naylor et al.
OSTEOPOROSIS INTERNATIONAL (2016)
Glucose-dependent insulinotropic polypeptide (GIP) dose-dependently reduces osteoclast differentiation and resorption
Guillaume Mabilleau et al.
BONE (2016)
Insulin Plays a Permissive Role for the Vasoactive Effect of GIP Regulating Adipose Tissue Metabolism in Humans
Meena Asmar et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2016)
Beneficial effects of a N-terminally modified GIP agonist on tissue-level bone material properties
Guillaume Mabilleau et al.
BONE (2014)
Glucose-Dependent Insulinotropic Polypeptide Inhibits Bone Resorption in Humans
Anne Nissen et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2014)
A Functional Amino Acid Substitution in the Glucose-Dependent Insulinotropic Polypeptide Receptor (GIPR) Gene Is Associated With Lower Bone Mineral Density and Increased Fracture Risk
S. S. Torekov et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2014)
Glucose-dependent insulinotropic polypeptide receptor deficiency leads to modifications of trabecular bone volume and quality in mice
Christine Gaudin-Audrain et al.
BONE (2013)
Glucose-dependent insulinotropic polypeptide (GIP) receptor deletion leads to reduced bone strength and quality
Aleksandra Mieczkowska et al.
BONE (2013)
Effect of glucagon-like peptide-2 exposure on bone resorption: Effectiveness of high concentration versus prolonged exposure
Carsten Askov-Hansen et al.
REGULATORY PEPTIDES (2013)
The Effect of Oral Glucose Tolerance Test on Serum Osteocalcin and Bone Turnover Markers in Young Adults
P. M. Paldanius et al.
CALCIFIED TISSUE INTERNATIONAL (2012)
International Osteoporosis Foundation and International Federation of Clinical Chemistry and Laboratory Medicine Position on bone marker standards in osteoporosis
Samuel Vasikaran et al.
CLINICAL CHEMISTRY AND LABORATORY MEDICINE (2011)
Incretin Hormone and Insulin Responses to Oral Versus Intravenous Lipid Administration in Humans
Ola Lindgren et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2011)
Cellular and Molecular Mechanisms of Bone Remodeling
Liza J. Raggatt et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Diurnal variation in serum markers of type I collagen synthesis and degradation in healthy premenopausal women
Christian Hassager et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2010)
The effect of glucagon-like peptide-2 on arterial blood flow and cardiac parameters
Lasse Bremholm et al.
REGULATORY PEPTIDES (2010)
Four-month treatment with GLP-2 significantly increases hip BMD A randomized, placebo-controlled, dose-ranging study in postmenopausal women with low BMD
Dennis B. Henriksen et al.
BONE (2009)
Glucagon-like peptide-2 increases mesenteric blood flow in humans
Lasse Bremholm et al.
SCANDINAVIAN JOURNAL OF GASTROENTEROLOGY (2009)
Disassociation of bone resorption and formation by GLP-2 - A 14-day study in healthy postmenopausal women
Dennis B. Henriksen et al.
BONE (2007)
Effects of glucose-dependent insulinotropic peptide on osteoclast function
Qing Zhong et al.
AMERICAN JOURNAL OF PHYSIOLOGY-ENDOCRINOLOGY AND METABOLISM (2007)
Glucose-dependent insulinotropic polypeptide receptor knockout mice have altered bone turnover
D Xie et al.
BONE (2005)
Pathophysiology of age-related bone loss and osteoporosis
S Khosla et al.
ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA (2005)
Reduction of nocturnal rise in bone resorption by subcutaneous GLP-2
DB Henriksen et al.
BONE (2004)
Role of gastrointestinal hormones in postprandial reduction of bone resorption
DB Henriksen et al.
JOURNAL OF BONE AND MINERAL RESEARCH (2003)
Octreotide abolishes the acute decrease in bone turnover in response to oral glucose
JA Clowes et al.
JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM (2003)
Mechanism of circadian variation in bone resorption
NH Bjarnason et al.
BONE (2002)
Structure, measurement, and secretion of human glucagon-like peptide-2
B Hartmann et al.
PEPTIDES (2000)
分享论文
